AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
Deng, LM; Bao, WM; Zhang, BF; Zhang, SA; Chen, ZY; Zhu, XW; He, BJ; Wu, LJ; Chen, XH; Deng, T; Chen, B; Yu, ZP; Wang, Y; Chen, G
Chen, G (通讯作者)，Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Wenzhou 325035, Peoples R China.;Chen, G (通讯作者)，Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Diag & Treatment Severe Hepatopancreat Dis, Wenzhou, Zhejiang, Peoples R China.;Wang, Y (通讯作者)，Wenzhou Med Univ, Sch Publ Hlth & Management, Dept Epidemiol & Biostat, Wenzhou 325035, Peoples R China.;Chen, G (通讯作者)，Wenzhou Med Univ, Affiliated Hosp 1, Hepatobiliary Pancreat Tumor Bioengn Cross Int Joi, Wenzhou 325035, Peoples R China.
CELL DEATH & DISEASE, 2023; 14 (9):
